Who Just Raised

BioGene Therapeutics Inc.

Austin, TX ยท Biotechnology

BioGene Therapeutics Inc. is a biotechnology company based in Austin, Texas. In a Form D filed with the SEC on August 7, 2026, it reported raising $3,000,000 from 1 investor as part of an offering of up to $3,000,000. The first sale in the offering took place on June 5, 2026.

BioGene Therapeutics is at the forefront of developing novel therapeutic solutions for metabolic disorders.

Website
biogenetherapeutics.com
Amount raised
$3,000,000
Offering size
$3,000,000
Investors so far
1
First sale
June 5, 2026
Securities offered
Options or warrants, Securities issuable on exercise or conversion
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Austin, Texas
Incorporated
Texas, 2024
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $3,000,000 $3,000,000 1 SEC filing
D (new notice) $3,000,000 $3,000,000 1 SEC filing
D (new notice) $250,000 $250,000 1 SEC filing
D (new notice) $250,000 $250,000 1 SEC filing

Figures come from the company's own filings with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Texas

Company Location Sector Raised Target Filed
FibroBiologics, Inc. Houston, TX Health Care $1.2M $1.2M
Lucier Pharmaceuticals Inc. Bryan, TX Health Care โ€” $2M
Surgical Caregivers of Fort Worth, LLC Fort Worth, TX Health Care โ€” $498K
TMF1 Akido, LLC Houston, TX Health Care โ€” $1M
OncoNano Medicine, Inc. Dallas, TX Health Care $10.1M $15M
Pressio, Inc. San Antonio, TX Health Care $544K $6M